These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11399341)

  • 1. Activation of circulating platelets and platelet response to activating agents in children with cyanotic congenital heart disease: their relevance to palliative systemic-pulmonary shunt.
    Kierzkowska B; Stańczyk J; Wiectawska B; Rózalski M; Boncler M; Chrul S; Watala C
    Int J Cardiol; 2001 Jun; 79(1):49-59. PubMed ID: 11399341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia.
    Horigome H; Hiramatsu Y; Shigeta O; Nagasawa T; Matsui A
    J Am Coll Cardiol; 2002 Mar; 39(6):1072-7. PubMed ID: 11897453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived microparticles and platelet function profile in children with congenital heart disease.
    Ismail EA; Youssef OI
    Clin Appl Thromb Hemost; 2013; 19(4):424-32. PubMed ID: 22914812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of duct stenting and modified Blalock-Taussig shunt in cyanotic congenital heart disease with duct-dependent pulmonary circulation.
    Lekchuensakul S; Somanandana R; Namchaisiri J; Benjacholamas V; Lertsapcharoen P
    Heart Vessels; 2022 May; 37(5):875-883. PubMed ID: 34714397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The young platelet population in children with cyanotic congenital heart disease.
    Goldschmidt B; Sorland SJ
    Thromb Haemost; 1976 Apr; 35(2):342-9. PubMed ID: 989634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thrombogenesity in patients with cyanotic congenital heart disease.
    Kajimoto H; Nakazawa M; Murasaki K; Mori Y; Tanoue K; Kasanuki H; Nakanishi T
    Circ J; 2007 Jun; 71(6):948-53. PubMed ID: 17526995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation in congenital heart diseases.
    Olgun N; Uysal KM; Irken G; Unal N; Undar B; Akkoç N; Akçoral A; Sarialioğlu F; Cevik N
    Acta Paediatr Jpn; 1997 Oct; 39(5):566-9. PubMed ID: 9363654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombo-hemorrhagic liability in children with congenital heart diseases.
    Shebl SS; El-Shehaby WAN; Said YS; Darwish AH; Elfadaly NH; Amer E
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):123-128. PubMed ID: 28867175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.
    Jensen AS; Johansson PI; Bochsen L; Idorn L; Sørensen KE; Thilén U; Nagy E; Furenäs E; Søndergaard L
    Int J Cardiol; 2013 Sep; 167(5):2210-4. PubMed ID: 22727966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: Role of immature platelet fraction.
    Matter RM; Ragab IA; Roushdy AM; Ahmed AG; Aly HH; Ismail EA
    Congenit Heart Dis; 2018 Jan; 13(1):118-123. PubMed ID: 28880458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated reactivity of whole blood neonatal platelets to various agonists.
    Pietrucha T; Wojciechowski T; Greger J; J drzejewska E; Nowak S; Chrul S; Golański J; Watala C
    Platelets; 2001 Mar; 12(2):99-107. PubMed ID: 11297038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease.
    Sahoo TK; Chauhan S; Sahu M; Bisoi A; Kiran U
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):179-83. PubMed ID: 17418728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased platelet reactivity identified by whole blood flow cytometry in Fanconi anaemia patients.
    Holzhauer S; Sitaru AG; Ebell W; Schindler D; Hanenberg H; Wirbelauer J; Walter U; Grossmann R
    Thromb Haemost; 2007 Dec; 98(6):1291-7. PubMed ID: 18064327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass.
    Rinder CS; Gaal D; Student LA; Smith BR
    J Thorac Cardiovasc Surg; 1994 Jan; 107(1):280-8. PubMed ID: 8283897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
    Furman MI; Benoit SE; Barnard MR; Valeri CR; Borbone ML; Becker RC; Hechtman HB; Michelson AD
    J Am Coll Cardiol; 1998 Feb; 31(2):352-8. PubMed ID: 9462579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.
    Jensen AS; Johansson PI; Idorn L; Sørensen KE; Thilén U; Nagy E; Furenäs E; Søndergaard L
    Int J Cardiol; 2013 Aug; 167(4):1317-21. PubMed ID: 22578951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.
    Holmes MB; Sobel BE; Howard DB; Schneider DJ
    Thromb Res; 1999 Jul; 95(2):75-82. PubMed ID: 10418796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet hyporeactivity in young infants during cardiopulmonary bypass.
    Ichinose F; Uezono S; Muto R; Uchida H; Hatori F; Terui K; Niimi Y; Goto T; Nakata Y; Morita S
    Anesth Analg; 1999 Feb; 88(2):258-62. PubMed ID: 9972737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine mesenteric venous graft as an alternative conduit in patients with cyanotic heart disease with e-polytetrafluoroethylene graft failure caused by thrombophilic factor positivity after modified Blalock-Taussig shunt.
    Akbulut B; Dogan OF; Guvener M; Yilmaz M; Yorgancioglu C; Karagoz T; Ozkutlu S; Demircin M; Dogan R
    Heart Surg Forum; 2008; 11(1):E37-41. PubMed ID: 18270138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functions of thrombin receptors in the reversible distribution of platelet surface glycoprotein I balpha in activated platelets].
    Han Y; Pasquet JM; Nurden A; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):152-6. PubMed ID: 15946527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.